Aug 02,2018

Insulet Reports Second Quarter 2018 Revenue of $124.3 Million, Up 13% Year-Over-Year, and Gross Margin of 66%, Up 710 Basis Points

Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced financial results for the three months ended June 30, 2018. The Company's second quarter 2018 revenue increased 13% to $124.3 million, compared to revenue of $109.8 million in the second quarter of 2017.

View Analyst & Ambassador Comments
Go to original news
Aug 02,2018

Beurer "Specialist Brand of the Year" for the third time in a row

Once again, the Plus X Award called on Germany's specialist trade to vote for the best specialist trade brands. Beurer was able to defend its title and is "Specialist Brand of the Year 2018" in the "Health & Personal Care" sector. The renowned special award is given to companies that work in a particularly responsible and cooperative manner with the specialist trade.

View Analyst & Ambassador Comments
Go to original news
Aug 07,2018

Senseonics Begins U.S. Commercialization of Eversense Continuous Glucose Monitoring System With First Shipment, First Users and First Policy Coverage

Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced that the Eversense® CGM System is now available at trained clinics across the U.S. and physicians have begun sensor placements with patients. Concurrently, the company reported that its first commercial payer, Horizon Blue Cross Blue Shield of New Jersey and Horizon Healthcare of New Jersey, has added coverage of the Eversense System to its Medical Policy.

PRODUCT

#cgm

View Analyst & Ambassador Comments
Go to original news
Aug 08,2018

Senseonics Holdings, Inc. Reports Second Quarter 2018 Financial Results

Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today reported financial results for the second quarter ended June 30, 2018. The Company's revenue was $3.6 million for the second quarter of 2018, compared to $0.8 million for the second quarter of 2017 and $2.9 million for the first quarter of 2018.

View Analyst & Ambassador Comments
Go to original news
Aug 08,2018

Tandem Diabetes Care Announces Publication of PROLOG Study Results in Diabetes Care Journal

Tandem Diabetes Care®, Inc., a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring (CGM) integration, today announced the online publication of results from the PROLOG (PLGS for Reduction of Low Glucose) study of the t:slim X2™ Insulin Pump with Basal-IQ™ predictive low glucose suspend technology in the medical journal Diabetes Care. The study demonstrated that the t:slim X2 Pump with Basal-IQ Technology significantly reduced hypoglycemia without rebound hyperglycemia, compared to time on a t:slim X2 Pump with integrated CGM and no automated insulin suspension. No severe adverse events were observed in the study during use of the Basal-IQ feature.

CLINICAL STUDY

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Aug 09,2018

DarioHealth Reports Second Quarter 2018 Results

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today reported financial and operational results for the second quarter ended June 30, 2018. The Company's revenue for the second quarter ended June 30, 2018 was $2.06 million, a 70% increase from $1.2 million in the second quarter ended June 30, 2017, and a 17% increase sequentially from the first quarter of 2018.

View Analyst & Ambassador Comments
Go to original news
Aug 09,2018

Medtronic Launches Patient Engagement Program That Leverages Gamification to Help Motivate and Engage Patients Living with Diabetes

Medtronic today announced the official U.S. launch of the Medtronic Inner CircleSM patient engagement program, which uses gamification - the application of game design elements - to motivate and encourage people living with diabetes to achieve better health outcomes.

PRODUCT
View Analyst & Ambassador Comments
Go to original news
Aug 09,2018

Nemaura Medical Inc. Reports First Quarter 2018 Financial Results

Nemaura Medical Inc., a medical technology company developing sugarBEAT® as a non-invasive glucose trending device for use by persons with diabetes and pre-diabetics today reported financial results for the first quarter ended June 30, 2018. Research and development expenses increased to $429,539 over the quarter ending June 2018, an increase from $149,198 for the same quarter in 2017.

View Analyst & Ambassador Comments
Go to original news
Aug 15,2018

DarioHealth to Exhibit at American Association of Diabetes Educators Conference on August 17-20 in Baltimore

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today it will exhibit the DarioEngage platform and its other digital health products at the American Association of Diabetes Educators (AADE) annual conference at booth #348 on August 17-20, 2018 in Baltimore, Maryland.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Aug 16,2018

Insulet to Showcase Its Omnipod DASH™ Insulin Management System at the American Association of Diabetes Educators Annual Conference

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced it will showcase its recently FDA cleared Omnipod DASH™ Insulin Management System (Omnipod DASH System), during the American Association of Diabetes Educators meeting at the Baltimore Convention Center in Baltimore, Maryland on August 17-20, 2018.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES